Literature DB >> 6414357

Endolymphatic hydrops. An overview and classification.

H F Schuknecht, A J Gulya.   

Abstract

Endolymphatic hydrops (EH) is a pathological condition which is the final common manifestation of a variety of otologic insults. In this paper we develop a classification which, on the basis of clinical and pathological data, distinguishes symptomatic and asymptomatic forms. Clinical case histories and temporal bone studies are presented to illustrate and substantiate this classification. The symptomatic form becomes evident by the hallmark symptoms of episodic vertigo and fluctuating hearing loss. The asymptomatic form is silent. Interconversion from one form to another may occur over time. Each of the forms can be subdivided, according to etiology, into embryopathic, acquired, and idiopathic types. The embryopathic type comprises those cases in which some noxious influence interferes with prenatal labyrinthine development. The acquired type includes those cases in which a documented insult, be it inflammatory or traumatic, is suffered by a previously normal labyrinth. The inflammation may be viral, bacterial, or spirochetal in nature, while the traumatic event may be either accidentally or surgically sustained. The idiopathic type includes cases in which the instigating event precipitating the EH is unknown. Menière's disease represents merely one example of the EH group of disorders, namely symptomatic idiopathic EH.

Entities:  

Mesh:

Year:  1983        PMID: 6414357     DOI: 10.1177/00034894830920s501

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  35 in total

1.  [Transtympanic administration of gentamicin in Menière diseases--less is more!?].

Authors:  A Koitschev
Journal:  HNO       Date:  2003-11       Impact factor: 1.284

2.  Menière's disease.

Authors:  H Ludman
Journal:  BMJ       Date:  1990-12-01

3.  Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla.

Authors:  Shinji Naganawa; Tomomi Komada; Hiroshi Fukatsu; Takeo Ishigaki; Osamu Takizawa
Journal:  Eur Radiol       Date:  2005-11-03       Impact factor: 5.315

Review 4.  [Endolymph homeostasis and Menière's disease: fundamentals, pathological changes, aminoglycosides].

Authors:  O Gleich; J Strutz; K Schmid
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

Review 5.  Ménière's disease.

Authors:  S N Merchant; S D Rauch; J B Nadol
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Menière's disease patients?

Authors:  Gerd Claes; Luc Van den Hauwe; Floris Wuyts; Paul Van de Heyning
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-28       Impact factor: 2.503

7.  Sequence of vestibular deficits in patients with noise-induced hearing loss.

Authors:  Chia-Chen Tseng; Yi-Ho Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-10       Impact factor: 2.503

8.  Assessing residual vestibular function in adults with congenital hearing loss.

Authors:  Bing-Yi Lin; Yi-Ho Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-13       Impact factor: 2.503

9.  Assessment of endolymphatic hydrops and otolith function in patients with Ménière's disease.

Authors:  Tomoko Okumura; Takao Imai; Yasumitsu Takimoto; Noriaki Takeda; Tadashi Kitahara; Atsuhiko Uno; Takefumi Kamakura; Yasuhiro Osaki; Yoshiyuki Watanabe; Hidenori Inohara
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

10.  A three-dimensional analysis of the endolymph drainage system in Ménière disease.

Authors:  Rafael da Costa Monsanto; Henrique F Pauna; Geeyoun Kwon; Patricia A Schachern; Vladimir Tsuprun; Michael M Paparella; Sebahattin Cureoglu
Journal:  Laryngoscope       Date:  2016-07-21       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.